---
document_datetime: 2023-09-21 20:57:32
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/okedi-epar-all-authorised-presentations_en.pdf
document_name: okedi-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7952394
conversion_datetime: 2025-12-20 02:13:12.072753
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form                                               | Route of Administration   | Immediate Packaging                                                  | Content (concentration)          | Pack size                                               |
|------------------|-------------------|------------|-------------------------------------------------------------------|---------------------------|----------------------------------------------------------------------|----------------------------------|---------------------------------------------------------|
| EU/1/21/1621/001 | OKEDI             | 75 mg      | Powder and solvent for prolonged-release suspension for injection | Intramuscular use         | Powder: pre- filled syringe (COP) Solvent: pre- filled syringe (COP) | Powder: 75 mg Solvent: 0.383 ml  | 1 pre-filled syringe + 1 pre-filled syringe + 2 needles |
| EU/1/21/1621/002 | OKEDI             | 100 mg     | Powder and solvent for prolonged-release suspension for injection | Intramuscular use         | Powder: pre- filled syringe (COP) Solvent: pre- filled syringe (COP) | Powder: 100 mg Solvent: 0.490 ml | 1 pre-filled syringe + 1 pre-filled syringe + 2 needles |